| Melissa D Gerardo, NP-C | |
|
2300 W Sunnyside Ave, Visalia, CA 93277-7287 | |
| (888) 744-2637 | |
| Not Available |
| Full Name | Melissa D Gerardo |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 2300 W Sunnyside Ave, Visalia, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023579505 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LG0600X | Nurse Practitioner - Gerontology | NP95011402 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaweah Delta Medical Center | Visalia, CA | Hospital |
| Adventist Health Hanford | Hanford, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sequoia Institute For Surgical Services Inc | 8022301928 | 6 |
News Archive
Rush University Medical Center has once again been named one of the nation's top hospitals in the nation, according to the upcoming issue of U.S.News & World Report.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.
A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria participated.
Jubilant Discovery Services Inc., Bedminster, New Jersey, a Jubilant Life Sciences Company, announced today that it has entered into a drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium, that will aim to deliver preclinical candidates to Janssen. The alliance is set to span an initial period of 3 years and will focus on multiple targets in the area of neuroscience.
› Verified 9 days ago
| Entity Name | Sequoia Institute For Surgical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255791422 PECOS PAC ID: 8022301928 Enrollment ID: O20160730000012 |
News Archive
Rush University Medical Center has once again been named one of the nation's top hospitals in the nation, according to the upcoming issue of U.S.News & World Report.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.
A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria participated.
Jubilant Discovery Services Inc., Bedminster, New Jersey, a Jubilant Life Sciences Company, announced today that it has entered into a drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium, that will aim to deliver preclinical candidates to Janssen. The alliance is set to span an initial period of 3 years and will focus on multiple targets in the area of neuroscience.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa D Gerardo, NP-C 2300 W Sunnyside Ave, Visalia, CA 93277-7287 Ph: () - | Melissa D Gerardo, NP-C 2300 W Sunnyside Ave, Visalia, CA 93277-7287 Ph: (888) 744-2637 |
News Archive
Rush University Medical Center has once again been named one of the nation's top hospitals in the nation, according to the upcoming issue of U.S.News & World Report.
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.
A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria participated.
Jubilant Discovery Services Inc., Bedminster, New Jersey, a Jubilant Life Sciences Company, announced today that it has entered into a drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium, that will aim to deliver preclinical candidates to Janssen. The alliance is set to span an initial period of 3 years and will focus on multiple targets in the area of neuroscience.
› Verified 9 days ago
George J Moussally, MSN,ACNP-BC,CCRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2000 | |
Kimberly Echevarria, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3130 W Caldwell Ave, Visalia, CA 93277 Phone: 559-635-7800 | |
Joanne Galindo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 221 E Caldwell Ave, Visalia, CA 93277 Phone: 559-732-4726 | |
San Juanita Barbosa Castellano, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5400 W. Hillsdale Drive, Visalia, CA 93291 Phone: 559-738-7500 Fax: 559-627-0106 | |
Mrs. Julieann Gonzales, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7500 | |
Jessica Nicole Jaimez, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1633 S Court St, Visalia, CA 93277 Phone: 559-624-2000 |